Login / Signup

Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review.

Noushin RostampourRojin CheginiSilva HovsepianFarzaneh ZamanehMahin Hashemipour
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
It is suggested that Phe levels between 120 and 360 μmol/L are generally safe. Some studies showed that untreated patients with higher levels might show some degrees of cognitive impairment. In conclusion, current knowledge is insufficient to state that treatment is not required for HPA patients to preserve their cognitive status, especially in patients with Phe levels of 360-600 μmol/L. Further studies with a larger sample size and standardized cognitive function evaluation tools are needed.
Keyphrases
  • cognitive impairment
  • end stage renal disease
  • ejection fraction
  • healthcare
  • prognostic factors
  • patient reported
  • smoking cessation